Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy

NCT00574405 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: MDI (split-mix NPH insulin + regular insulin or Lantus + Novolog® [or Humalog®])
DEVICE: CSII (Animas Corporation insulin pump, model IR 1200)

Sponsor

Arkansas Children's Hospital Research Institute